Gavin Herbert Eye Institute, Sue & Bill Gross Stem Cell Research Center, University of California, Irvine, CA 92697, USA.
Neuroscience Research Institute, University of California, Santa Barbara, CA 93106, USA.
Int J Mol Sci. 2024 Jul 24;25(15):8060. doi: 10.3390/ijms25158060.
Photoreceptor degeneration is a major cause of untreatable blindness worldwide and has recently been targeted by emerging technologies, including cell- and gene-based therapies. Cell types of neural lineage have shown promise for replacing either photoreceptors or retinal pigment epithelial cells following delivery to the subretinal space, while cells of bone marrow lineage have been tested for retinal trophic effects following delivery to the vitreous cavity. Here we explore an alternate approach in which cells from the immature neural retinal are delivered to the vitreous cavity with the goal of providing trophic support for degenerating photoreceptors. Rat and human retinal progenitor cells were transplanted to the vitreous of rats with a well-studied photoreceptor dystrophy, resulting in substantial anatomical preservation and functional rescue of vision. This work provides scientific proof-of-principle for a novel therapeutic approach to photoreceptor degeneration that is currently being evaluated in clinical trials.
光感受器变性是全球范围内无法治疗的失明的主要原因,最近新兴技术包括基于细胞和基因的疗法已经将其作为靶点。神经谱系的细胞类型在递送至视网膜下腔后显示出替代光感受器或视网膜色素上皮细胞的潜力,而骨髓谱系的细胞在递送至玻璃体腔后已被测试用于视网膜营养作用。在这里,我们探索了一种替代方法,即将来自未成熟神经视网膜的细胞递送至玻璃体腔,以提供对变性光感受器的营养支持。将大鼠和人视网膜祖细胞移植到具有研究良好的光感受器变性的大鼠玻璃体中,导致大量的解剖保存和视觉功能恢复。这项工作为一种新型的光感受器变性治疗方法提供了科学原理的证明,目前正在临床试验中进行评估。